NSD Bio Group, LLC – North American Advisory firm, has been tapped by the U.S. China Economic and Security Review Commission, to conduct special research and analyses on the increasing role of China’s raw ingredients used in pharmaceutical products and dietary supplements manufactured and sold in the U.S. marketplace. As a result of China’s continued prominence as a global Pharmaceutical supply destination, there is increasing concern over potential health and public safety outcomes of the unregulated use of Chinese-origin raw materials in today’s drugs and nutritional supplements in the U.S. NSD Bio Group, LLC is a specialized consultancy that provides advisory services and special analyses to companies and governmental entities on issues of commercialization, strategic assessments, and sovereign importance within the international Biotechnology and Nanotechnology sectors. U.S. China Economic and Security Review Commission was established by Congress to monitor and report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.
